# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
- SEC Filing
-SEC Filing
Molecular Templates shares are volatile Tuesday after the company presented interim data from MT-6402 Phase I study in patients...
The poster highlighted the following findings from the phase I dose-escalation study of MT-6402:MT-6402 has been well tolerated...